US Stock MarketDetailed Quotes
SLRX Salarius Pharmaceuticals
- 1.4100
- -0.0500-3.42%
Trading Nov 22 09:34 ET
2.03MMarket Cap-274P/E (TTM)
1.4200High1.4100Low827Volume1.4200Open1.4600Pre Close1.17KTurnover0.06%Turnover RatioLossP/E (Static)1.44MShares7.272052wk High0.69P/B1.98MFloat Cap1.260052wk Low--Dividend TTM1.40MShs Float124099.9504Historical High--Div YieldTTM0.69%Amplitude1.2600Historical Low1.4110Avg Price1Lot Size
Salarius Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -56.68%3.28M | -71.64%3.27M | -52.84%4.37M | -51.27%5.9M | -51.27%5.9M | -54.93%7.58M | -49.04%11.54M | -61.67%9.27M | -58.56%12.11M | -58.56%12.11M |
| -Cash and cash equivalents | -56.68%3.28M | -71.64%3.27M | -52.84%4.37M | -51.27%5.9M | -51.27%5.9M | -54.93%7.58M | -49.04%11.54M | -61.67%9.27M | -58.56%12.11M | -58.56%12.11M |
| Receivables | ---- | ---- | ---- | --0 | --0 | --0 | --130K | --130K | --1.61M | --1.61M |
| -Other receivables | ---- | ---- | ---- | ---- | ---- | ---- | --130K | --130K | --1.61M | --1.61M |
| Prepaid assets | ---- | ---- | ---- | --0 | --0 | --0 | --0 | -83.49%11.19K | -88.53%11.19K | -88.53%11.19K |
| Other current assets | -27.53%538.62K | -15.36%241.07K | -13.01%457.06K | -21.77%619.76K | -21.77%619.76K | -34.50%743.2K | -14.60%284.81K | -11.71%525.44K | -6.98%792.19K | -6.98%792.19K |
| Total current assets | -54.08%3.82M | -70.61%3.51M | -51.41%4.83M | -55.10%6.52M | -55.10%6.52M | -53.67%8.32M | -48.05%11.96M | -60.01%9.94M | -51.86%14.52M | -51.86%14.52M |
| Non current assets | ||||||||||
| Other non current assets | -54.60%36.52K | -59.69%39.93K | -53.51%53.39K | -48.77%66.85K | -48.77%66.85K | -45.07%80.44K | -39.02%99.05K | -32.80%114.85K | -32.69%130.5K | -32.69%130.5K |
| Total non current assets | -54.60%36.52K | -59.69%39.93K | -53.51%53.39K | -48.77%66.85K | -48.77%66.85K | -95.42%80.44K | -99.07%99.05K | -98.92%114.85K | -98.78%130.5K | -98.78%130.5K |
| Total assets | -54.08%3.86M | -70.52%3.55M | -51.43%4.88M | -55.04%6.59M | -55.04%6.59M | -57.39%8.4M | -64.18%12.06M | -71.68%10.06M | -64.12%14.65M | -64.12%14.65M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | -84.77%165.8K | -71.89%643.05K | -79.66%713.96K | -78.91%602.85K | -78.91%602.85K | -36.58%1.09M | 22.00%2.29M | 107.33%3.51M | 85.23%2.86M | 85.23%2.86M |
| -accounts payable | -84.77%165.8K | -71.89%643.05K | -79.66%713.96K | -78.91%602.85K | -78.91%602.85K | -36.58%1.09M | 22.00%2.29M | 107.33%3.51M | 85.23%2.86M | 85.23%2.86M |
| Current accrued expenses | -43.07%439.93K | -60.46%535.42K | -59.07%403.31K | -71.11%406.75K | -71.11%406.75K | -44.56%772.79K | 51.30%1.35M | 152.51%985.39K | 147.96%1.41M | 147.96%1.41M |
| Current debt and capital lease obligation | -28.37%328.85K | ---- | --116.86K | --289.64K | --289.64K | --459.09K | ---- | ---- | ---- | ---- |
| -Current debt | -28.37%328.85K | ---- | --116.86K | --289.64K | --289.64K | --459.09K | ---- | ---- | ---- | ---- |
| Current liabilities | -59.73%934.58K | -67.64%1.18M | -72.55%1.23M | -69.55%1.3M | -69.55%1.3M | -25.40%2.32M | 31.47%3.64M | 114.89%4.5M | 102.10%4.27M | 102.10%4.27M |
| Non current liabilities | ||||||||||
| Total non current liabilities | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Total liabilities | -59.73%934.58K | -67.64%1.18M | -72.55%1.23M | -69.55%1.3M | -69.55%1.3M | -25.40%2.32M | 31.47%3.64M | 114.89%4.5M | 102.10%4.27M | 102.10%4.27M |
| Shareholders'equity | ||||||||||
| Share capital | -63.45%144 | -80.90%64 | 75.20%431 | 74.67%393 | 74.67%393 | 75.89%394 | -94.03%335 | -94.73%246 | 24.31%225 | 24.31%225 |
| -common stock | -63.45%144 | -80.90%64 | 75.20%431 | 74.67%393 | 74.67%393 | 75.89%394 | -94.03%335 | -94.73%246 | 24.31%225 | 24.31%225 |
| -Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Retained earnings | -6.62%-80.46M | -8.85%-79.49M | -12.90%-78.06M | -19.66%-76.35M | -19.66%-76.35M | -31.40%-75.47M | -69.72%-73.02M | -80.51%-69.15M | -98.17%-63.81M | -98.17%-63.81M |
| Paid-in capital | 2.25%83.38M | 0.52%81.86M | 9.38%81.71M | 10.04%81.63M | 10.04%81.63M | 10.13%81.55M | 10.19%81.44M | 4.17%74.7M | 4.61%74.19M | 4.61%74.19M |
| Total stockholders'equity | -51.93%2.92M | -71.77%2.38M | -34.35%3.65M | -49.09%5.29M | -49.09%5.29M | -63.38%6.08M | -72.76%8.41M | -83.36%5.56M | -73.18%10.38M | -73.18%10.38M |
| Total equity | -51.93%2.92M | -71.77%2.38M | -34.35%3.65M | -49.09%5.29M | -49.09%5.29M | -63.38%6.08M | -72.76%8.41M | -83.36%5.56M | -73.18%10.38M | -73.18%10.38M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data